The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Explore this paper's citation graph
Summary
A comprehensive overview on the current state of knowledge of the endocannabinoid system as a target of pharmacotherapy is provided.
- Type
- review
- Published
- 2006-09-01
- Cited by
- 2,087
- References
- 1,357
- Access
- Open access
- OpenAlex
- https://openalex.org/W2119826244
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:13780231
Keywords
Endocannabinoid system, Cannabinoid receptor, Rimonabant, Pharmacology, Neuroscience
References
- Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum.
- Corticotropin-releasing factor is altered in brains of animals with high preference for ethanol.
- The Efficacy and Safety of Nabilone (A Synthetic Cannabinoid) in the Treatment of Anxiety
- Gilles de la Tourette-Syndrom Einfluß von Nikotin, Alkohol und Marihuana auf die klinische Symptomatik
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptor
- Δ9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors
- Cannabinol derivatives: binding to cannabinoid receptors and inhibition of adenylylcyclase.
- Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.
- Marginally improved detection of GM1 antibodies by Covalink ELISA in multifocal motor neuropathy
- The effect of δ-9-tetrahydrocannabinol on forebrain ischemia in rat
- Cannabinoid receptor agonists inhibit depolarization‐induced calcium influx in cerebellar granule neurons
- Dexanabinol (HU-211) in the treatment of severe closed head injury: a randomized, placebo-controlled, phase II clinical trial.
- Cannabinoids in MS: potentially useful but not just yet!
- Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation.
- Tetrahydrocannabinol and endocannabinoids in feeding and appetite.
- Topically administered CB(2)-receptor agonist, JWH-133, does not decrease intraocular pressure (IOP) in normotensive rabbits.
- Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol‐induced dopamine release in the nucleus accumbens
- A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms
- CB(1) cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infarction.
- Up-regulation of murine double minute clone 2 (MDM2) gene expression in rat brain after morphine, heroin, and cocaine administrations.
Cited by
- The Effect of Endocannabinoid System on Energy Metabolism and Obesity
- Feeding disorders and obesity.
- Cannabinoids and atherosclerosis.
- Therapeutic potential of cannabinoid-based drugs.
- CB1 receptor antagonist AVE1625 affects primarily metabolic parameters independently of reduced food intake in Wistar rats.
- The stimulatory effect of phosphatidylethanolamine on N-acylphosphatidylethanolamine-hydrolyzing phospholipase D (NAPE-PLD).
- Amino acid residues crucial in pH regulation and proteolytic activation of N-acylethanolamine-hydrolyzing acid amidase.
- Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid
- The Use of a Synthetic Cannabinoid in the Management of Treatment‐Resistant Nightmares in Posttraumatic Stress Disorder (PTSD)
- Assessment of Hospice Health Professionals' Knowledge, Views, and Experience with Medical Marijuana
- Toxic Effects of Marijuana on the Cardiovascular System
- A cannabinoid type 2 receptor agonist attenuates blood–brain barrier damage and neurodegeneration in a murine model of traumatic brain injury
- Are alkyne reductions chemo-, regio-, and stereoselective enough to provide pure (Z)-olefins in polyfunctionalized bioactive molecules?
- ‘Tis in our nature: taking the human-cannabis relationship seriously in health science and public policy
- Effects of cannabinoids and related fatty acids upon the viability of P19 embryonal carcinoma cells
- Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C.
- Roles of the endocannabinoid system in learning and memory.
- New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity.
- Endocannabinoids drive the acquisition of an alternative phenotype in microglia.
- Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
Related papers
- The endocannabinoid system and obesity
- cFOS expression following rimonabant precipitated withdrawal from WIN 55212-2 in the rat brain
- Advance in the pharmacological study of rimonabant
- Cannabinoid-induced lower lip retraction in rats
- Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB1 receptor antagonist
- CB1 cannabinoid antagonists: structure-activity relationships and potential therapeutic applications.
- Role of the endocannabinoid system in metabolic control
- Behavioral pharmacology of cannabinoids
- Ligands for cannabinoid receptors, promising anticancer agents.